Farxiga Affordability Tips: From Discount Cards to Patient Assistance

GLP-1 weight loss drugs reduce food spending, creating a $6.5 billion challenge for major grocery retailers

The article discusses how GLP-1 weight loss drugs like tirzepatide are significantly impacting consumer spending on food, creating a $6.5 bi

Medicare begins covering weight-loss medications: who qualifies and how the new program will work

Medicare Launches $50/Month GLP-1 Weight-Loss Drug Trial: What Beneficiaries Need to Know

Starting this week, the federal government launched a new trial program called Medicare GLP-1 Bridge, offering certain GLP-1 agonist medicat

Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.

CMS Launches Medicare GLP-1 Bridge, Expanding Access to GLP-1 Medications

Copay assistance is meant to defray patient drug costs. Some insurers keep it instead.